- Jiyya
- Shaidun
- Neuroblastoma
- Ciwon daji mai ƙarfi
- Shaidun
- TILS
- Maganin Kwayoyin NK
- Myasthenia Gravis (MG)
- Ciwon sankarar lymphoblastic mai tsanani (B-ALL)
- Tsarin Lupus Erythematosus (SLE)
- Ciwon sankarar lymphoblastic mai tsanani (T-ALL)
- Lymphoma na Non-Hodgkin (NHL)
- Myeloma da yawa (MM)
- Babban Lymphom na B-cell da aka Yaɗu
- B-lymphocytic Leukemia
- Myeloma
CAR-T don Glioblastoma
-
Ƙwayar CAR-T
Maganin CAR-T (Chimeric Antigen Receptor T-cell) yana wakiltar wani nau'in maganin rigakafi na zamani. Ya ƙunshi gyara ƙwayoyin T ɗinku - wani nau'in ƙwayoyin rigakafi - don gane da kai hari kan ƙwayoyin cutar kansa waɗanda ke bayyana takamaiman alamomi. Ga glioblastoma, wannan maganin yana da nufin samar da magani na musamman wanda zai iya tsawaita rayuwa da rage alamun cutar, musamman idan aka haɗa shi da wasu hanyoyi.
Manufofi a cikin Maganin CAR-T don Glioblastoma
A cikin glioblastoma, wasu sunadarai a saman ƙwayoyin ciwon daji suna aiki a matsayin maƙasudai masu kyau don maganin CAR-T saboda yawan bayyanar ƙwayoyin cutar kansa da kuma ƙarancin kasancewarsu a cikin kyallen lafiya. A Bioocus, mun mayar da hankali kan manyan manufofi guda biyu:
- GD2: Wannan wani sinadari ne mai suna glycolipid antigen wanda aka fi samu a cikin ƙwayoyin glioblastoma, da kuma sauran ciwace-ciwacen kwakwalwa kamar su gliomas na tsakiya. GD2 yana da hannu a cikin siginar ƙwayoyin halitta kuma yana bayyana sosai a cikin ciwace-ciwacen masu tsanani, wanda hakan ya sa ya zama alama mai kyau don nisantar garkuwar jiki.
- B7-H3: Wanda aka fi sani da CD276, wannan furotin na gwajin garkuwar jiki yana da yawan gaske a cikin glioblastoma kuma yana taimakawa wajen guje wa ciwace-ciwacen tsarin garkuwar jiki. Yana taka rawa wajen haɓaka ci gaban ciwon daji da kuma danne martanin garkuwar jiki, wanda hakan ya sa ya zama abin da ake nema don haɓaka hare-haren ƙwayoyin T.
Ta hanyar injiniyan ƙwayoyin CAR-T don gane GD2 ko B7-H3, maganin yana jagorantar kai hari kan ƙwayoyin ƙari yayin da yake rage lalacewar kyallen kwakwalwa ta yau da kullun.
Yadda Maganin CAR-T ke Aiki: Tsarin Aiki
Maganin CAR-T yana farawa da tattara samfurin ƙwayoyin T ɗinku ta hanyar tsari makamancin gudummawar jini. Daga nan ana gyara waɗannan ƙwayoyin halitta a cikin dakin gwaje-gwaje don bayyana mai karɓar antigen na chimeric (CAR) - mai karɓar da aka keɓance wanda ke aiki kamar "na'urar gida" ga ƙwayoyin cutar kansa.
- Ganewa: CAR da ke kan ƙwayoyin T yana ɗaure musamman ga GD2 ko B7-H3 akan ƙwayoyin glioblastoma, kamar makulli da maɓalli.
- Kunnawa: Da zarar an ɗaure shi, CAR yana sa ƙwayoyin T su kunna, su ninka, kuma su saki ƙwayoyin sigina waɗanda ke haɗa sauran ƙwayoyin rigakafi don shiga yaƙin.
- Lalacewa: Kwayoyin T da aka kunna suna kai hari kai tsaye kuma suna kashe ƙwayoyin cutar kansa da aka yi niyya, wanda hakan na iya haifar da raguwar ƙari da rage nauyin cututtuka.
Wannan tsari yawanci ya ƙunshi sake shigar da ƙwayoyin T da aka gyara cikin jikinka, sau da yawa ta hanyar jijiya ko hanyoyin haihuwa da aka yi niyya don isa ga kwakwalwa. Manufar ita ce ƙirƙirar martanin rigakafi mai ɗorewa wanda ke ci gaba da sa ido da kuma kawar da sauran ƙwayoyin cutar kansa a kan lokaci.
Magungunan CAR-T ɗinmu suna niyya ne ga GD2 kuma B7-H3 don Glioblastomanuna ingantaccen tasiri a gwaje-gwajen asibiti.
Don GD2 CAR-Twani bincike da aka gudanar kan marasa lafiya 37 da suka sake komawa ko kuma suka sake yin gliomas masu inganci ya nuna cewa Matsakaicin amsawar da aka yi niyya kashi 72%, tare da Kashi 42% sun sami cikakkiyar gafara a makonni 6 kuma 56% sun ci gaba da kiyaye shi bayan shekaru 1.7 na bin diddigin cutar.
Don B7-H3 CAR-T, wani gwaji da aka yi wa manya 39 da ke fama da cutar glioblastoma mai maimaitawa ya ruwaito Adadin amsawar kashi 30–40% kuma Kashi 60–70% na rage kamuwa da cuta, tare da matsakaicin rayuwa na watanni 11 (lokacin da aka yi amfani da maganin guda ɗaya) da watanni 13.6 (haɗuwa), wanda ya zarce bayanan tarihi.
Duk magungunan biyu suna da aminci, tare da ƙananan illa masu sauƙi da sauƙin sarrafawa. Bioocus ya sadaukar da kansa ga haɓaka waɗannan magunguna masu ƙirƙira don inganta sakamako ga marasa lafiya na glioblastoma.
Maganin Radiation
Maganin rediyo mai jijiyoyi (SRT) ko Tsarin rediyo na jiki na stereotactic (SBRT) za a iya haɗa shi da CAR-T don kai hari ga yankunan ƙari daidai, rage girman da kuma haɓaka damar shiga ƙwayoyin garkuwar jiki. Wannan hanyar da aka yi amfani da ita sosai tana rage lalacewar kyallen jiki mai lafiya kuma tana iya inganta shigar CAR-T.
Tsarin Shiga-tsakani
Dasa barbashi ya haɗa da sanya ƙwayoyin rediyoaktif kai tsaye a cikin ƙari don samun radiation na gida, yana ƙara CAR-T ta hanyar raunana ƙwayoyin cutar kansa kafin a fara amfani da su. Don samun damar kwakwalwa, Madatsar ruwa ta Ommaya sanya magani yana ba da damar isar da magani kai tsaye zuwa cikin ruwan cerebrospinal, wanda hakan ke iya haɓaka rarrabawar CAR-T.
Madatsar Ruwa ta Ommaya
Wannan na'urar ta musamman, wacce aka sanya ta a ƙarƙashin fatar kai ta hanyar tiyata, yana ba da damar isar da magunguna kai tsaye zuwa cikin ruwan cerebrospinal ta hanyar catheter zuwa ga ventricles na kwakwalwaGa marasa lafiya da ke fama da cutar glioblastoma, musamman waɗanda ke da cutar leptomeningeal, Tafkin Ommaya yana ba da damar sarrafa ƙwayoyin CAR-T daidai ko wasu hanyoyin magani, tabbatar da yawan magunguna a cikin tsarin jijiyoyi na tsakiya tare da ƙarancin rashin jin daɗi idan aka kwatanta da hudawar lumbar.
Wannan dabarar multimodal tana da nufin ƙara girma iko kan cutar yayin da kake tallafawa murmurewa da walwalarka.
Tambayoyin da Ake Yawan Yi
- Shin na cancanci yin maganin CAR-T?Cancanta ya dogara ne akan abubuwa kamar nau'in ciwon daji, jiyya da aka yi a baya, da kuma lafiyar gaba ɗaya. Shawarwari da ƙwararrunmu na iya taimakawa wajen tantance ko ya dace da ku.
- Menene illar da ka iya faruwa?Wadanda aka fi sani sun hada da gajiya, alamomin da suka shafi kumburi, da kuma martanin garkuwar jiki, wadanda ake sa ido a kansu kuma ake kula da su sosai.
- Tsawon wane lokaci ne tsarin zai ɗauka?Daga tarin ƙwayoyin halitta zuwa jiko, yawanci yana ɗaukar makonni da yawa, tare da ci gaba da kula da su.
Idan kana la'akari da Maganin CAR-T don glioblastoma, muna nan don tallafa muku da kulawa mai tausayi da ta dogara da shaida. Tuntuɓi ƙungiyarmu a Bioocus don tsara lokacin tattaunawa da kuma koyon yadda wannan sabuwar hanyar za ta iya shiga cikin tsarin maganin ku. Lafiyar ku da begenku suna da mahimmanci a gare mu—bari mu bincika zaɓuɓɓuka tare.
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.